Vimian Group AB (publ) (STO: VIMIAN) Stock Analysis & Fundamentals | ScreenerHero

Create free account

VIMIANVimian Group AB (publ)

STO · SE · Healthcare · Diagnostics & Research · vimian.com

29.20SEK-0.85%Mkt Cap: 1.48B $P/E: 37.441d ago

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, pres…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/E

Pricier

P/B

Pricier

1M Perf

Avg

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.48B $

Enterprise Value1.49B $

Revenue (TTM)41.47M $

Gross Profit28.01M $

Net Income (TTM)2.99M $

Revenue/Share0.0787 USD

Last Price29.20 SEK

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1.3K

CountrySE

SectorHealthcare

IndustryDiagnostics & Research

ISINSE0015961982

Valuation

P/E (Trailing)37.44

P/E (Forward)21.95

PEG—

EV/EBITDA148.65

EV/Revenue35.96

P/S35.64

P/B21.39

EPS (TTM)0.78

EPS (Forward)1.33

52W Range

24.1826% of range43.58

52W High43.58 SEK

52W Low24.18 SEK

Profitability

Gross Margin68.89%

Oper. Margin18.19%

EBITDA Margin24.19%

Profit Margin7.36%

ROE4.48%

ROA2.82%

Growth

Revenue Growth7.90%

Earnings Growth125.60%

Cash Flow & Leverage

Operating CF10.11M $

CapEx (TTM)1.44M $

FCF Margin13.01%

FCF Yield0.37%

Net Debt18.88M $

Net Debt/EBITDA1.88

Balance Sheet

Debt/Equity0.34

Current Ratio1.71

Quick Ratio0.95

Book Value/Sh1.365 SEK

Cash/Share0.0960 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.2 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)35.32 SEK

Upside (mean)+21.0%

Target Range26.48 SEK – 41.07 SEK

SEK26.48+21.0% to meanSEK41.07

# Analysts6

Ownership

Shares Out.528.32M

Float185.43M

Insiders6.46%

Institutions86.70%

Technical

SMA 5029.49 (-1.0%)

SMA 20028.94 (+0.9%)

Beta1.17

S&P 52W Chg20.05%

Avg Vol (30d)469.05K

Avg Vol (10d)686.25K

Technical Indicators

RSI (14)47.9

MACD0.1796

MACD Signal0.1986

MACD Hist.-0.0190

BB Upper31.67 SEK

BB Middle29.28 SEK

BB Lower26.88 SEK

BB Width16.38%

ATR (14)1.192 SEK

Vol Ratio (20d)0.33x